{"id":"W2167222907","doi":"10.1016/j.nano.2012.02.009","title":"NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease","year":2012,"lang":"en","type":"review","venue":"Nanomedicine Nanotechnology Biology and Medicine","topic":"Nerve injury and regeneration","field":"Neuroscience","cited_by":57,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"National Institute on Drug Abuse; National Institutes of Health; Canadian Institutes of Health Research; Parkinson Society Canada","keywords":"Neurotrophic factors; Dopaminergic; Neuroscience; Vesicular monoamine transporter; Parkinson's disease; Nanocarriers; Neurodegeneration; Genetic enhancement; Nanomedicine; Medicine; Gene delivery; Pharmacology; Biology; Disease; Receptor; Internal medicine; Dopamine; Monoamine neurotransmitter; Nanotechnology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006509389,0.0007201238,0.002599576,0.0009211224,0.0002889067,0.000003743608,0.0005891992,0.001499279,0.0001029479],"category_scores_gemma":[0.001104029,0.0004371663,0.00031553,0.0006467927,0.00358975,0.00007353951,0.0001463731,0.0007372766,0.000006802546],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003492973,"about_ca_system_score_gemma":0.0002600845,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008979722,"about_ca_topic_score_gemma":0.000001130757,"domain_scores_codex":[0.9963794,0.0004600545,0.001145675,0.001072593,0.0002069158,0.0007353855],"domain_scores_gemma":[0.9973261,0.0006310963,0.0009257752,0.0007283661,0.00009023397,0.0002984723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002853373,0.0001211687,0.0000258716,0.002390598,0.00008108799,0.0000295359,0.00002916808,9.125142e-8,0.03777419,0.008751649,0.0002982405,0.9502131],"study_design_scores_gemma":[0.002021094,0.001890083,0.00001151391,0.001722743,0.0008171533,0.0002534533,0.000008244294,0.000007436621,0.00327662,0.001679162,0.9879429,0.0003695585],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002603945,0.9892362,0.0005781531,0.002476342,0.002620036,0.002107664,0.0002049659,0.0001436552,0.00002905372],"genre_scores_gemma":[0.03127377,0.9653041,0.00007648695,0.0007923383,0.001485275,0.0004972029,0.0001950406,0.00007158889,0.0003042048],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9876447,"threshold_uncertainty_score":0.999808,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08095032988275014,"score_gpt":0.3681600517702654,"score_spread":0.2872097218875153,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}